Hyldebrandt HK, Stormorken AT, Vitelli V, Geirdal AØ, Grindedal EM (2025)
Experiences with risk-reducing mastectomy in Norwegian BRCA1/2 carriers without prior breast cancer
Fam Cancer, 24 (3), 60
DOI 10.1007/s10689-025-00484-6, PubMed 40728683

Hendricks LAJ, Verbeek KCJ, Schuurs-Hoeijmakers JHM, de Putter R, Brems H, Van Daele SH, Anastasiadou VC, Foretová L, Benusiglio PR, Gerasimenko A, Colas C, Villy MC, Houdayer C, Branchaud M, Hüneburg R, Aretz S, Jahn A, Steinke-Lange V, Innella G, Turchetti D, Barili V, Genuardi M, Panfili A, Baldassarri M, Irmejs A et al. (2025)
Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)-a European cohort study
BJC Rep, 3 (1), 42
DOI 10.1038/s44276-025-00157-y, PubMed 40468016

Hendricks LAJ, Verbeek KCJ, Schuurs-Hoeijmakers JHM, de Jong MM, Links TP, Brems H, Aerden M, Brunet J, Lleuger-Pujol R, Hüneburg R, Aretz S, Colas C, Villy MC, Woodward ER, Evans DG, Bosch DGM, Donze SH, Foretová L, Blatnik A, Leter EM, Tischkowitz M, Jahn A, de Putter R, Dupont J, Briskemyr S et al. (2025)
The risk of a second primary cancer in PTEN Hamartoma Tumor Syndrome (PHTS)
Genet Med, 101467 (in press)
DOI 10.1016/j.gim.2025.101467, PubMed 40433764